The FDA has approved a groundbreaking new drug to slow the progression of Alzheimer's disease in its early stages, offering ...

Two new drugs, the first capable of slowing down the debilitating progression of Alzheimer's disease, have become embroiled ...

Vigil Neuroscience said the Food and Drug Administration removed a partial clinical hold on its ongoing Phase 1 clinical trial of a treatment for Alzheimer's disease, VG-3927. The clinical-stage ...

The new Alzheimer’s drug Kinsula is offering hope for patients by slowing down the progression of the disease. Neurologist Dr. Mauricio Concha administered the drug ...

But the healthcare system in the US still struggles to provide adequate care for those with serious mental illness ...

For Lennart Mucke, MD, founding director of the Gladstone Institute of Neurological Disease, these new drugs mark an ...

The FDA and manufacturers routinely allow doctors and hospitals to continue using medical devices that could cause serious harm or death.

Researchers at UCLA Health have discovered a molecule that shows promise in restoring memory and cognitive function in mice ...

As Gladstone Institutes commemorates World Alzheimer’s Month, Lennart Mucke, MD, discusses what’s next for Alzheimer’s ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

THURSDAY, Sept. 11, 2024 (HealthDay News) -- Two monoclonal antibody treatments to slow Alzheimer's disease, lecanemab ...

Registered dietitian nutritionist Carrie Dennett explains what nicotinamide adenine dinucleotide, or NAD, is and if it has ...